Ryan Proctor, DO
Procedural Dermatology · Bullhead City, AZNPI 1972861326
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.8% of the total across 103 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by AbbVie at 35.0% of the total. 2025 is the largest year on record at $951, 3.6 times the $261 reported in 2019.
Across 103 payments — averaging $23.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$832
- Galderma Laboratories, L.p.$492
- Amgen$225
- Johnson & Johnson$127
- Organogenesis Inc.$121
- Pfizer$115
- plus $466 from 10 others
What the payments were for
- Food & beverage$2,27996%
- Education$994%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 46 | $832 |
| Galderma Laboratories, L.p. | 16 | $492 |
| Amgen | 12 | $225 |
| Johnson & Johnson | 3 | $127 |
| Organogenesis Inc. | 4 | $121 |
| Pfizer | 3 | $115 |
| LEO Pharma Inc. | 3 | $88 |
| Regeneron Healthcare Solutions, Inc. | 2 | $76 |
| Sanofi | 2 | $66 |
| Mimedx Group, Inc. | 4 | $66 |
| Biofrontera Inc. | 3 | $54 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $42 |
| Bristol Myers Squibb | 1 | $23 |
| Boehringer Ingelheim | 1 | $22 |
| Dermavant Sciences, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEMLUVIO$120
How this compares
Too few procedural dermatology providers in Arizonato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 11 | $228,632 |
| Clobetasol Propionate | 48 | $3,772 |
| Triamcinolone Acetonide | 342 | $2,401 |
| Fluorouracil | 27 | $2,155 |
| Mycophenolate Mofetil | 13 | $1,792 |
| Mupirocin | 232 | $1,592 |
| Doxycycline Hyclate | 104 | $1,339 |
| Ketoconazole | 94 | $1,335 |
| Fluocinonide | 33 | $1,102 |
| ValacyclovirValacyclovir Hcl | 31 | $1,017 |
| Ammonium Lactate | 68 | $976 |
| Cephalexin | 149 | $850 |
| Betamethasone Dipropionate | 18 | $745 |
| Tretinoin | 12 | $726 |
| MethotrexateMethotrexate Sodium | 50 | $514 |
Paid to pharmacies, not to this prescriber.
Other procedural dermatology in Bullhead City
- Glenn ZellmanPhoenix$1M
- Jody ComstockTucson$155K
- Brenda LatowskyScottsdale$152K
- Marc EpsteinTucson$13K
- Anne GoldsberryScottsdale$5K
- Ronald MannTucson$5K
- Jordan MillerFlagstaff$4K
- Madeline ParsonPhoenix$3K
- Keith MackenziePrescott$1K
- Neel PatelPhoenix$828
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.